Business News • PR NewsWire • Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate

Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate

Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate

-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, Feb. 8 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Li

View More : http://www.prnewswire.com/news-releases/medicago-receives-fda-regulatory-clearance-to-initiate-us-clinical-trial-for-a-n...

Releted News by prnewswire